Влияние курсового приема L-орнитин- L-аспартата на фиброз и стеатоз печени у больных ассоциированной с нарушениями метаболизма жировой болезнью печени (неалкогольной жировой болезнью печени), имеющих гипераммониемию
Introduction. Hyperammonaemia develops both in cirrhosis and earlier fibrotic stages during metabolic-associated fatty liver disease (MAFLD). Besides neurotropic, ammonia exerts the hepatotoxic and profibrotic effects. L-ornithine-L-aspartate (LOLA) has been proved effective in treatment for hyperam...
Saved in:
Main Author: | Е. V. Garanina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2021-12-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/635 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Сhanges in subcellular distribution of lysosomal cysteine proteinases activity in parenchymatous organs of rats under the action of nitric oxide synthesis modulators
by: M. A. Fomina, et al.
Published: (2018-09-01) -
Efficacy and safety of the Russian protease inhibitor narlaprevir at treatment-naive and earlier treated noncirrhotic patients with the 1st genotype chronic hepatitis C (PIONEER study)
by: M. V. Mayevskaya, et al.
Published: (2018-08-01) -
Gender and age features in adults with congenital heart disease
by: I.G. Lebid
Published: (2017-09-01) -
Competitive purposefulness
by: O. V. Mikhailov
Published: (2019-04-01) -
The Perspectives of the Russian-USA Relationships: the Echo of the “Cold War” or the “Reset”
by: E. S. Chimiris
Published: (2011-04-01)